Does Device Make Any Difference? A Real-world Retrospective Study of Insulin Treatment Among Elderly Patients With Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: We compared real-world clinical and economic outcomes for insulin glargine treatment administered by disposable pen and traditional vial-and-syringe injections among elderly patients with type 2 diabetes mellitus (T2DM). Methods: Using a large database of US retirees, this retrospective longitudinal study examined 1-year follow-up outcomes in patients with T2DM aged 65 years or older who were either insulin naïve and initiated insulin glargine via disposable pen (pen initiators [PI]) or vial (vial initiators [VI]) or were already insulin glargine users but either continued with a vial (vial continuers [VC]) or switched to a disposable pen (pen switchers [PS]). Results: There were 7856 propensity-score-matched patients, including 2930 each in the PI and VI cohorts, and 998 each in the VC and PS cohorts. Compared with vial-and-syringe users, the disposable pen users had significantly greater treatment persistence ( P < .0001 for both comparisons), duration of persistence ( P < .0001 for both), and adherence ( P < .01 for both) and lower insulin daily average consumption ( P < .05 for both). Compared with the VI cohort, the PI cohort had significantly fewer hypoglycemia-related events ( P = .0164). Total health care costs were comparable for the respective matched cohorts. Conclusions: In elderly patients with T2DM receiving insulin glargine therapy, initiating or switching to a disposable pen was associated with better treatment persistence and adherence than initiating or continuing with vial-and-syringe, without increased total health care costs. Among insulin-naïve patients, initiating insulin glargine by disposable pen was also associated with significantly reduced risk of hypoglycemia compared with vial-and-syringe patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kirkman, M. S., Briscoe, V. J., Clark, N., Florez, H., Haas, L. B., Halter, J. B., Huang, E. S., Korytkowski, M. T., Munshi, M. N., Odegard, P. S., et al. (2012) · Diabetes Care · doi:10.2337/dc12-1801 · Cited by 1,274 · cited 2×
“This has resulted in a lack of knowledge of how to treat this group of patients.(8) The successful management of T2DM in elderly patients represents a challenge, as this patient group has a high risk of premature death, functional disability, cognitive impairment, injurious falls, and serious comorbid illnesses such a…”
BackgroundHypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus
Whitmer, R. A. (2009) · JAMA · doi:10.1001/jama.2009.460 · Cited by 1,128 · cited 1×
“Frail elderly patients are especially likely to develop complications from hypoglycemia, such as dementia.(30) Insulin remains a viable treatment option for many older patients and, as diabetes progresses with age, the majority of patients will likely require insulin to achieve adequate glycemic control.”
BackgroundHealth economics and compliance of vials/syringes versus pen devices: a review of the evidence
Asche, C. V., Shane-McWhorter, L., & Raparla, S. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0180 · Cited by 83
Cited by
Guerci, B., Chanan, N., Kaur, S., Jasso-Mosqueda, J. G., & Lew, E. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0590-x · Cited by 106
A Systematic Review of Insulin Adherence Measures in Patients with Diabetes
Stolpe, S., Kroes, M. A., Webb, N., & Wisniewski, T. (2016) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2016.22.11.1224 · Cited by 77
Slabaugh, S. L., Bouchard, J. R., Li, Y., Baltz, J. C., Meah, Y. A., & Moretz, D. C. (2015) · Advances in Therapy · doi:10.1007/s12325-015-0266-5 · Cited by 41
Steenkamp, D., Eby, E. L., Gulati, N., & Liao, B. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/1932296821997923 · Cited by 33
Trends in U.S. Insulin Use and Glucose Monitoring for People with Diabetes: 2009-2018
Perez-Nieves, M., Juneja, R., Fan, L., Meadows, E., Lage, M. J., & Eby, E. L. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211028268 · Cited by 22
Metadata
- Authors
- Miao, R., Wei, W., Lin, J., Xie, L., & Baser, O.
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2014-01
- Volume
- 8
- Issue
- 1
- Pages
- 150-158
- ISSN
- 1932-2968 (ISSN-L)
- OpenAlex
- W2163572103
- Cited by
- 22
- References
- 3
- FWCI
- 1.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Does Device Make Any Difference? A Real-world Retrospective Study of Insulin Treatment Among Elderly Patients With Type 2 Diabetes. https://app.cochat.ai/papers/10.1177/1932296813516956
- The paper
- Miao, R., Wei, W., Lin, J., Xie, L., & Baser, O. (2014). Does Device Make Any Difference? A Real-world Retrospective Study of Insulin Treatment Among Elderly Patients With Type 2 Diabetes. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296813516956
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.